Elevance Health Service fees — Product and service revenue increased by 3.9% to $2.25B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.5%, from $2.07B to $2.25B. Over 3 years (FY 2022 to FY 2025), Service fees — Product and service revenue shows an upward trend with a 4.4% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase suggests successful diversification into high-margin health service sectors and deeper integration into the care delivery ecosystem. A decrease may indicate reduced demand for non-insurance services or a shift in the company's service-based business strategy.
This metric represents revenue generated from non-insurance service offerings, such as pharmacy benefit management, care...
Peers in the managed care industry often report this as 'Health Services' or 'Pharmacy Services' revenue, which is typically compared based on the percentage of total revenue contribution.
elv_segment_service_fees_product_and_service_revenue| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.86B | $1.86B | $1.86B | $1.86B | $2.01B | $1.93B | $2.04B | $1.92B | $2.08B | $2.28B | $2.02B | $2.03B | $2.07B | $2.11B | $2.14B | $2.16B | $2.25B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +7.8% | -3.9% | +6.0% | -6.0% | +8.1% | +9.6% | -11.2% | +0.3% | +1.9% | +1.9% | +1.4% | +1.1% | +3.9% |
| YoY Change | — | — | — | — | +7.8% | +3.5% | +9.7% | +3.2% | +3.5% | +18.0% | -1.0% | +5.6% | -0.4% | -7.4% | +5.6% | +6.5% | +8.5% |